Literature DB >> 22090401

Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories.

Teresa Spanu1, Brunella Posteraro, Barbara Fiori, Tiziana D'Inzeo, Serena Campoli, Alberto Ruggeri, Mario Tumbarello, Giulia Canu, Enrico Maria Trecarichi, Gabriella Parisi, Mirella Tronci, Maurizio Sanguinetti, Giovanni Fadda.   

Abstract

We evaluated the reliability of the Bruker Daltonik's MALDI Biotyper system in species-level identification of yeasts directly from blood culture bottles. Identification results were concordant with those of the conventional culture-based method for 95.9% of Candida albicans (187/195) and 86.5% of non-albicans Candida species (128/148). Results were available in 30 min (median), suggesting that this approach is a reliable, time-saving tool for routine identification of Candida species causing bloodstream infection.

Entities:  

Mesh：

Year:  2011        PMID： 22090401      PMCID： PMC3256727          DOI： 10.1128/JCM.05742-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals.

Authors:  Matteo Bassetti; Enrico Maria Trecarichi; Elda Righi; Maurizio Sanguinetti; Francesca Bisio; Brunella Posteraro; Ornella Soro; Roberto Cauda; Claudio Viscoli; Mario Tumbarello
Journal:  Diagn Microbiol Infect Dis       Date:  2007-03-09       Impact factor: 2.803

4.  Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  O Bader; M Weig; L Taverne-Ghadwal; R Lugert; U Gross; M Kuhns
Journal:  Clin Microbiol Infect       Date:  2010-12-03       Impact factor: 8.067

5.  Time to positive culture and identification for Candida blood stream infections.

Authors:  Julianna Fernandez; Brian L Erstad; Wanda Petty; David E Nix
Journal:  Diagn Microbiol Infect Dis       Date:  2009-05-15       Impact factor: 2.803

6.  Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol.

Authors:  Michael Gherna; William G Merz
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

7.  Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory.

Authors:  Maurizio Sanguinetti; Rosaria Porta; Michela Sali; Marilena La Sorda; Giovanni Pecorini; Giovanni Fadda; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

8.  MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers.

Authors:  Jiang Qian; Jim E Cutler; Richard B Cole; Yang Cai
Journal:  Anal Bioanal Chem       Date:  2008-08-09       Impact factor: 4.142

9.  Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.

Authors:  Mario Tumbarello; Brunella Posteraro; Enrico Maria Trecarichi; Barbara Fiori; Marianna Rossi; Rosaria Porta; Katleen de Gaetano Donati; Marilena La Sorda; Teresa Spanu; Giovanni Fadda; Roberto Cauda; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

10.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079
View more
  59 in total

1.  MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units.

Authors:  G Pulcrano; E Roscetto; V D Iula; D Panellis; F Rossano; M R Catania
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-30       Impact factor: 3.267

2.  Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures.

Authors:  B Fiori; T D'Inzeo; A Giaquinto; G Menchinelli; F M Liotti; F de Maio; G De Angelis; G Quaranta; D Nagel; M Tumbarello; B Posteraro; M Sanguinetti; T Spanu
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

Review 3.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.

Authors:  Andrew E Clark; Erin J Kaleta; Amit Arora; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  A differential centrifugation protocol and validation criterion for enhancing mass spectrometry (MALDI-TOF) results in microbial identification using blood culture growth bottles.

Authors:  G A March-Rosselló; M F Muñoz-Moreno; M C García-Loygorri-Jordán de Urriés; M A Bratos-Pérez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-30       Impact factor: 3.267

5.  Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time.

Authors:  Philippe R S Lagacé-Wiens; Heather J Adam; James A Karlowsky; Kimberly A Nichol; Paulette F Pang; Jodi Guenther; Amanda A Webb; Crystal Miller; Michelle J Alfa
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

6.  Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry systems.

Authors:  Jonathan H K Chen; Pak-Leung Ho; Grace S W Kwan; Kevin K K She; Gilman K H Siu; Vincent C C Cheng; Kwok-Yung Yuen; Wing-Cheong Yam
Journal:  J Clin Microbiol       Date:  2013-03-20       Impact factor: 5.948

7.  An in-house assay is superior to Sepsityper for direct matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry identification of yeast species in blood cultures.

Authors:  Marie Bidart; Isabelle Bonnet; Aurélie Hennebique; Zine Eddine Kherraf; Hervé Pelloux; François Berger; Muriel Cornet; Sébastien Bailly; Danièle Maubon
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

8.  Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.

Authors:  Ayman M Abdelhamed; Sean X Zhang; Tonya Watkins; Margie A Morgan; Fann Wu; Rebecca J Buckner; DeAnna D Fuller; Thomas E Davis; Hossein Salimnia; Marilynn R Fairfax; Paul R Lephart; Melinda D Poulter; Sarah B Regi; Michael R Jacobs
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

9.  Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

Review 10.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Use with Positive Blood Cultures: Methodology, Performance, and Optimization.

Authors:  Matthew L Faron; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2017-08-30       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.